Overview
Status
Active
Registry date
2023-08-25
Share capital
5,000.00 PLN
Registered address
Konopna 16, 95-200 Pabianice, Poland
Electronic delivery address
AE:PL-61095-78143-AUTBV-27
Financials
Revenue history
Filing timeliness
Financial statements were filed on time, on average 9 days early.
- 2025filed
- 202411/07/2025
- 202302/07/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Aleksander Daniel Orzełowski – President of the Management Board
Anna Magdalena Wołosz – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Aleksander Daniel Orzełowskiage 49 | 85 | $1,148.03 | 85% |
Anna Magdalena Wołoszage 44 | 15 | $202.59 | 15% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-10-12.
58 1240 1545 1978 0011 2990 2237
57 1240 1545 1111 0011 2990 2149
50 1240 1545 1789 0011 2990 2325
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| OMET Medicalsp. z o.o. | $1,867,545.06 | ometmedical.pl | ||
| Cytogen - Polskasp. z o.o. | $1,127,200.51 | cytogen.com.pl | ||
| Goldfarmexsp. z o.o. | $710,510.28 | goldfarmex.pl | ||
| Orthoactivesp. z o.o. | $617,449.08 | orthoactive.pl | ||
| Tecnobody Polskasp. z o.o. | $508,641.92 | mtt.net.pl | ||
| CanpolandS.A. | $328,824.15 | canpoland.com | ||
| Geneco Groupsp. z o.o. | $156,220.50 | genecocontact.pl | ||
| Novaova Sosnowski Wadowskisp. k. | $54,452.69 | novaova.pl | ||
| Endolink PharmaS.A. | $7,191.18 | endolink.pl | ||
| Novaovasp. z o.o. | $0.16 | novaova.pl |
FAQ
The main business activity of Global Ortho Solutions focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on August 25, 2023.
The headquarters is located at: Konopna 16, 95-200 Pabianice.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $6,870 in 2024, which is an increase of 54.9% compared to 2023.
Yes, the company recorded a net profit of $807 in 2024, meaning the company decreased its profit by 57.8%.
The largest operating cost category falls under materials and energy. This category amounted to $4,023 in 2024, representing 75% of all operating expenses.
Last updated: 2026-04-25